Status:
COMPLETED
Immunological Characteristics of a Population at Risk of Cholera After Oral Cholera Vaccine (CHOVAXIM)
Lead Sponsor:
Centre for Infectious Disease Research in Zambia
Collaborating Sponsors:
Johns Hopkins University
European and Developing Countries Clinical Trials Partnership (EDCTP)
Conditions:
Diarrhea Infectious
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of the study is to find out if individuals who received first and second dose of Oral Cholera Vaccine (OCV) in Lukanga Swamps, Central Province of Zambia have developed protection against ...
Detailed Description
Cholera is caused by toxigenic strains of Vibrio cholerae O1 and O139 and is characterised by sudden onset of acute watery diarrhoea that can lead to severe dehydration and ultimately death if not tre...
Eligibility Criteria
Inclusion
- Participants aged 18-65 years are eligible to participate.
- Participant is a resident of the study area. Residence was defined as individuals living in the study area for the past 1 year.
- Written consent provided by participant.
Exclusion
- Participant aged less than 18 years
- Refuses to consent to participate
- Pregnancy
- Participant has acute medical illness prior to receipt of oral cholera vaccine -Participant has a history of hospitalization for cholera in the past one week
Key Trial Info
Start Date :
October 16 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2020
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT04423159
Start Date
October 16 2016
End Date
October 31 2020
Last Update
July 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Waya clinic
Kabwe, Central Province, Zambia, 10101